Advances in our understanding of drug hypersensitivity

Clinical and Experimental Allergy

Volumn 43, Issue 11, 2013, Pages 1200-1201

  Brockow, K ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL;

CYTOTOXIC T LYMPHOCYTE; DRUG HYPERSENSITIVITY; EDITORIAL; HLA SYSTEM; HUMAN; IMMUNOPATHOGENESIS; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

ALLOPURINOL; DRUG HYPERSENSITIVITY; GOUT SUPPRESSANTS; HUMANS; OXYPURINOL; T-LYMPHOCYTES;

EID: 84886313899     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12193     Document Type: Editorial

References (12)

1. Demoly P, Adkinson N, Brockow K et al. International Consensus (ICON) on Drug Allergy. Allergy 2013. [In press].
2. Gell P, Coombs R. The classification of allergic reactions underlying disease. In: Gell P, Coombs R, eds. Clinical aspects of immunology. Oxford: Blackwell Science, 1963:217-37.
3. Levine B, Ovary Z. Studies on the mechanism of the formation of the penicillin antigen. J Exp Med 1961; 114:875-904.
4. Castrejon JL, Berry N, El-Ghaiesh S et al. Stimulation of human T cells with sulfonamides and sulfonamide metabolites. J Allergy Clin Immunol 2010; 125:411-8.
5. Pichler WJ. Drug hypersensitivity reactions: classification and relationship to T-cell activation. In: Pichler WJ, ed. Drug hypersensitivity. Basel: Karger, 2007:168-89.
6. Pichler WJ. Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept. Curr Opin Allergy Clin Immunol 2002; 2:301-5.
7. Ostrov DA, Grant BJ, Pompeu YA et al. Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire. Proc Natl Acad Sci USA 2012; 109:9959-64.
8. Illing PT, Vivian JP, Dudek NL et al. Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature 2012; 486:554-8.
9. Phillips EJ, Chung WH, Mockenhaupt M, Roujeau JC, Mallal SA. Drug hypersensitivity: pharmacogenetics and clinical syndromes. J Allergy Clin Immunol 2011; 127:S60-6.
10. Yun J, Mattsson J, Schnyder K et al. Allopurinol hypersensitivity is primarily mediated by dose-dependent oxypurinol-specific T cell response. Cin Exp Allergy 2013; 43:1246-55.
11. Stamp LK, Taylor WJ, Jones PB et al. Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol. Arthritis Rheum 2012; 64:2529-36.
12. Hande KR, Noone RM, Stone WJ. Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency. Am J Med 1984; 76:47-56.